The Traderszone Network

Published in TZ Latest News 8 February, 2017 by The TZ Newswire Staff

Axovant Rival’s Alzheimer Drug Fails Study

Danish drug maker Lundbeck’s 5-HT6 Alzheimer’s drug failed, clearing the way for Axovant.